Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive (Loss) Income	Non-controlling Interest
Balance, beginning of period (in shares) at Dec. 31, 2019			105,851,285		19,943,432
Balance, beginning of period at Dec. 31, 2019		$ 2,545,712	$ 1	$ 2,097,995	$ (343,524)	$ 782,350	$ 884	$ 8,006
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		249,527				243,439		6,088
Other comprehensive income (loss)		(2,050)					(2,050)
Exercise of stock options (in shares)			551,845
Exercise of stock options		9,579		9,579
Issuance of restricted stock units, net of shares withheld for tax (in shares)	[1]		687,818
Issuance of restricted stock units, net of shares withheld for tax	[1]	(9,228)		(9,228)
Issuance of equity in connection with business combinations (in shares)			28,327,290
Issuance of equity in connection with business combinations		787,877		787,877
Repurchase of common stock (shares)			(5,941,324)		(5,941,324)
Repurchase of common stock		(103,332)			$ (103,332)
Common stock surrendered in connection with warrant exercise		0
Stock compensation expense		27,023		27,023
Stock compensation expense related to WLH acquisition		5,106		5,106
WLH equity award accelerations due to change in control		8,421		8,421
Distributions to non-controlling interests of consolidated joint ventures		(46,938)						(46,938)
Changes in non-controlling interests of consolidated joint ventures		122,053						122,053
Balance, end of period (in shares) at Dec. 31, 2020			129,476,914		25,884,756
Balance, end of period at Dec. 31, 2020		3,593,750	$ 1	2,926,773	$ (446,856)	1,025,789	(1,166)	89,209
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		682,367				663,026		19,341
Other comprehensive income (loss)		1,855					1,855
Exercise of stock options (in shares)			1,204,283
Exercise of stock options		23,331		23,331
Issuance of restricted stock units, net of shares withheld for tax (in shares)	[1]		392,050
Issuance of restricted stock units, net of shares withheld for tax	[1]	(5,420)		(5,420)
Warrant exercises (in shares)			1,704,205
Warrant exercises		$ 32,584		32,584
Repurchase of common stock (shares)		(9,918,104)	(9,918,104)		(9,918,104)
Repurchase of common stock		$ (281,420)			$ (281,420)
Common stock surrendered in connection with warrant exercise (in shares)			(1,025,699)		(1,025,699)
Common stock surrendered in connection with warrant exercise		(32,587)			$ (32,587)
Stock compensation expense		19,943		19,943
Distributions to non-controlling interests of consolidated joint ventures		(62,734)						(62,734)
Changes in non-controlling interests of consolidated joint ventures		(687)						(687)
Balance, end of period (in shares) at Dec. 31, 2021			121,833,649		36,828,559
Balance, end of period at Dec. 31, 2021		3,970,982	$ 1	2,997,211	$ (760,863)	1,688,815	689	45,129
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		1,056,247				1,052,800		3,447
Other comprehensive income (loss)		(330)					(330)
Exercise of stock options (in shares)			323,625
Exercise of stock options		6,697		6,697
Issuance of restricted stock units, net of shares withheld for tax (in shares)	[1]		406,352
Issuance of restricted stock units, net of shares withheld for tax	[1]	$ (5,320)		(5,320)
Repurchase of common stock (shares)		(14,568,364)	(14,568,364)		(14,568,364)
Repurchase of common stock		$ (376,275)			$ (376,275)
Common stock surrendered in connection with warrant exercise		0
Stock compensation expense		26,901		26,901
Distributions to non-controlling interests of consolidated joint ventures		(31,261)						(31,261)
Changes in non-controlling interests of consolidated joint ventures		(782)						(782)
Balance, end of period (in shares) at Dec. 31, 2022			107,995,262		51,396,923
Balance, end of period at Dec. 31, 2022		$ 4,646,859	$ 1	$ 3,025,489	$ (1,137,138)	$ 2,741,615	$ 359	$ 16,533

[1] Dollar amount represents the value of shares withheld for taxes.